US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Hutchison China Meditech

13.81

-0.3500-2.47%

Post-market: 13.810.00000.00%16:10 EDT

Volume:31.59K

Turnover:438.64K

Market Cap:2.41B

PE:5.31

High:14.14

Open:13.99

Low:13.72

Close:14.16

52wk High:19.50

52wk Low:11.51

Shares:174.43M

Float Shares:104.00M

Volume Ratio:1.40

T/O Rate:0.03%

Dividend:- -

Dividend Rate:- -

EPS(TTM):2.60

EPS(LYR):2.60

ROE:45.25%

ROA:-1.62%

PB:1.95

PE(LYR):5.31

Loading ...

Overview Company News Filings

Malaysian Shares Rebound Mirroring Regional Gains; Vetece's Shares Rise 4%

MT Newswires Live

Hutchmed Starts Phase III Trial of Pancreatic Cancer Treatment Combination

MT Newswires Live

Vetece Unit Wins About MYR13 Million HCM Cloud Deal

MT Newswires Live

HUTCHMED (00013) Initiates Phase III Stage of Ongoing Study of Surufatinib Combined with Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma

Hutchmed Says New Application for Gastric Cancer Treatment Gets Priority Review in China

MT Newswires Live

HUTCHMED (00013) Announces NDA Acceptance and Priority Review Status in China for Savolitinib in MET-Amplified Gastric Cancer

Hutchmed Says Chinese Regulator Granted Priority Review Status to New Drug Application for Fanregratinib

MT Newswires Live

HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review

Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms

Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China for Patients with Obstructive Hypertrophic Cardiomyopathy

Hutchmed Begins Phase 1 Study of HMPL-A251 Monotherapy to Treat Patients With Solid Tumors

MT Newswires Live

HUTCHMED (00013) Initiates Global Clinical Development of ATTC Candidate HMPL-A251 for Solid Tumors

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Press Release: UKG Agrees to Acquire Inova Payroll

Tenaya Therapeutics Announces Proposed Public Offering

Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC

ADP Unveils Lyric HCM in Australia and New Zealand

HUTCHMED (00013): TAZVERIK® Included in the First National Commercial Health Insurance Innovative Drug List

Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum

AI-Powered Event Notifications Might Change the Case for Investing in Paychex (PAYX)

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/HCM/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HCM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCM\",,,,,undefined,":{"symbol":"HCM","market":"US","secType":"STK","nameCN":"Hutchison China Meditech","latestPrice":13.81,"timestamp":1774641600000,"preClose":14.16,"halted":0,"volume":31588,"hourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"16:10 EDT","volume":32,"amount":441.92,"timestamp":1774642204451,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.02471751412429376,"floatShares":104000000,"shares":174433934,"eps":2.599995,"marketStatus":"Market Closed","change":-0.35,"latestTime":"03-27 16:00:00 EDT","open":13.99,"high":14.14,"low":13.72,"amount":438639.88574,"amplitude":0.029661,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":2.599995,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":1,"adrRate":5,"listingDate":1458187200000,"exchange":"NASDAQ","adjPreClose":14.16,"postHourTrading":{"tag":"盘后","latestPrice":13.81,"preClose":13.81,"latestTime":"16:10 EDT","volume":32,"amount":441.92,"timestamp":1774642204451,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.404311,"impliedVol":0.6996,"impliedVolPercentile":0.8167},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCM\",,,,,undefined,":{"symbol":"HCM","floatShares":104000000,"roa":"-1.62%","roe":"45.25%","lyrEps":2.599995,"volumeRatio":1.404311,"shares":174433934,"dividePrice":0,"high":14.14,"amplitude":0.029661,"preClose":14.16,"low":13.72,"week52Low":11.505,"pbRate":"1.95","psRate":"4.39","week52High":19.5,"institutionHeld":0,"latestPrice":13.81,"eps":2.599995,"divideRate":0,"volume":31588,"delay":0,"ttmEps":2.599995,"open":13.99,"prevYearClose":13.33,"prevWeekClose":13.94,"prevMonthClose":14.33,"prevQuarterClose":13.33,"fiveDayClose":13.94,"twentyDayClose":14.33,"sixtyDayClose":13.2},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HCM\",params:#limit:5,,,undefined,":[{"date":"2026-03-05","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1772701200000,"name":null,"time":"Pre-Market","dateTimestamp":1772686800000,"actualEps":null},{"market":"US","date":"2025-08-07","symbol":"HCM","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-03-19","symbol":"HCM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"date":"2024-07-31","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":null,"defaultRemindTime":1722412800000,"name":null,"time":"Pre-Market","dateTimestamp":1722398400000,"actualEps":null},{"date":"2024-02-28","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1709110800000,"name":null,"time":"Pre-Market","dateTimestamp":1709096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HCM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HCM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.1667,"sell":0.0833,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1758513600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HCM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HCM","date":"2026-03-27","current":5.311549,"percent":0.725714,"low":-115.327022,"twenty":-64.328552,"median":-11.319534,"eighty":5.577919,"high":86.489551,"avg":-20.086328,"sd":44.098676,"marketCap":2259466792.96},"quantilePoints":[{"date":"2021-04-01","current":-32.26063,"twenty":-86.192609,"median":-40.508564,"eighty":-27.778854,"marketCap":4056129016.55},{"date":"2021-04-09","current":-33.137949,"twenty":-84.984122,"median":-40.185037,"eighty":-27.776445,"marketCap":4166434318.18},{"date":"2021-04-16","current":-34.129797,"twenty":-84.235269,"median":-40.070583,"eighty":-27.776445,"marketCap":4291139241.78},{"date":"2021-04-23","current":-34.843079,"twenty":-84.024169,"median":-40.002655,"eighty":-27.776445,"marketCap":4380820320.94},{"date":"2021-04-30","current":-34.438006,"twenty":-83.830644,"median":-39.797322,"eighty":-27.776445,"marketCap":4329890574.8},{"date":"2021-05-07","current":-31.821317,"twenty":-83.830644,"median":-39.648909,"eighty":-27.776445,"marketCap":4000894157.31},{"date":"2021-05-14","current":-30.312709,"twenty":-83.490922,"median":-39.473341,"eighty":-27.776445,"marketCap":3811216913.73},{"date":"2021-05-21","current":-32.458918,"twenty":-83.490922,"median":-39.204978,"eighty":-27.776445,"marketCap":4081059812.14},{"date":"2021-05-28","current":-34.354172,"twenty":-83.387891,"median":-38.87818,"eighty":-27.776445,"marketCap":4319349995.04},{"date":"2021-06-04","current":-35.068157,"twenty":-82.646756,"median":-38.63441,"eighty":-27.776445,"marketCap":4409119282.86},{"date":"2021-06-11","current":-35.414599,"twenty":-81.346061,"median":-38.54063,"eighty":-27.776445,"marketCap":4452677569.33},{"date":"2021-06-18","current":-34.032624,"twenty":-77.803409,"median":-38.350657,"eighty":-27.776445,"marketCap":4278921905.79},{"date":"2021-06-25","current":-35.828259,"twenty":-76.471988,"median":-38.192608,"eighty":-27.732156,"marketCap":5400465105.51},{"date":"2021-07-02","current":-43.838432,"twenty":-74.83281,"median":-38.175147,"eighty":-27.732156,"marketCap":6607854466.82},{"date":"2021-07-09","current":-41.097094,"twenty":-74.120934,"median":-38.175147,"eighty":-27.732156,"marketCap":6194647318.34},{"date":"2021-07-16","current":-44.549309,"twenty":-72.365744,"median":-38.175147,"eighty":-27.732156,"marketCap":6715006390.46},{"date":"2021-07-23","current":-45.310589,"twenty":-70.91277,"median":-38.175147,"eighty":-27.732156,"marketCap":6829755650.02},{"date":"2021-07-30","current":-39.696122,"twenty":-69.643297,"median":-38.175147,"eighty":-27.732156,"marketCap":7083098072.62},{"date":"2021-08-06","current":-40.119386,"twenty":-69.529012,"median":-38.24796,"eighty":-27.870771,"marketCap":7158622428.55},{"date":"2021-08-13","current":-39.097534,"twenty":-69.529012,"median":-38.459009,"eighty":-28.149056,"marketCap":6976290399.57},{"date":"2021-08-20","current":-36.065012,"twenty":-69.529012,"median":-38.476067,"eighty":-28.245756,"marketCap":6435188201.17},{"date":"2021-08-27","current":-35.744125,"twenty":-69.529012,"median":-38.476067,"eighty":-28.472218,"marketCap":6377931431.79},{"date":"2021-09-03","current":-40.719987,"twenty":-69.529012,"median":-38.500254,"eighty":-28.576552,"marketCap":7265789374.3},{"date":"2021-09-10","current":-37.614485,"twenty":-69.529012,"median":-38.500254,"eighty":-28.654578,"marketCap":6711665355.27},{"date":"2021-09-17","current":-36.698865,"twenty":-69.529012,"median":-38.500254,"eighty":-28.733157,"marketCap":6548288680.59},{"date":"2021-09-24","current":-35.293788,"twenty":-69.529012,"median":-38.500254,"eighty":-29.073592,"marketCap":6297576451.05},{"date":"2021-10-01","current":-34.394618,"twenty":-69.529012,"median":-38.500254,"eighty":-29.166917,"marketCap":6137134715.17},{"date":"2021-10-08","current":-32.006355,"twenty":-69.529012,"median":-38.500254,"eighty":-29.281853,"marketCap":5710989951.59},{"date":"2021-10-15","current":-30.941818,"twenty":-69.529012,"median":-38.500254,"eighty":-29.322519,"marketCap":5521041305.66},{"date":"2021-10-22","current":-31.083316,"twenty":-69.529012,"median":-38.500254,"eighty":-29.56411,"marketCap":5546289439.2},{"date":"2021-10-29","current":-28.737101,"twenty":-69.529012,"median":-38.500254,"eighty":-29.623518,"marketCap":5127647054.8},{"date":"2021-11-05","current":-29.069569,"twenty":-69.529012,"median":-38.500254,"eighty":-29.71681,"marketCap":5186970395.65},{"date":"2021-11-12","current":-29.581373,"twenty":-69.529012,"median":-38.500254,"eighty":-29.71681,"marketCap":5278293116.21},{"date":"2021-11-19","current":-29.210209,"twenty":-69.529012,"median":-38.500254,"eighty":-29.770213,"marketCap":5212065210.66},{"date":"2021-11-26","current":-34.003345,"twenty":-69.529012,"median":-38.500254,"eighty":-29.883033,"marketCap":6067318798.77},{"date":"2021-12-03","current":-32.23822,"twenty":-69.529012,"median":-38.500254,"eighty":-29.920748,"marketCap":5752362415.71},{"date":"2021-12-10","current":-32.455639,"twenty":-69.529012,"median":-38.500254,"eighty":-29.981314,"marketCap":5791157109.58},{"date":"2021-12-17","current":-33.631509,"twenty":-69.529012,"median":-38.500254,"eighty":-30.078029,"marketCap":6000971032.9},{"date":"2021-12-23","current":-34.093269,"twenty":-69.529012,"median":-38.500254,"eighty":-30.131346,"marketCap":6083364180.02},{"date":"2021-12-31","current":-34.446938,"twenty":-69.529012,"median":-38.500254,"eighty":-30.191644,"marketCap":6146470612.85},{"date":"2022-01-07","current":-32.437839,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":5787980958.33},{"date":"2022-01-14","current":-30.159284,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":5381411525.89},{"date":"2022-01-21","current":-28.701706,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":5121331366.35},{"date":"2022-01-28","current":-25.003785,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4461500388},{"date":"2022-02-04","current":-26.206511,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4676106460.92},{"date":"2022-02-11","current":-25.261882,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4507553408.67},{"date":"2022-02-18","current":-25.371388,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4527092765.71},{"date":"2022-02-25","current":-25.683001,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4582694996.65},{"date":"2022-03-04","current":-18.605078,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3621441412.39},{"date":"2022-03-11","current":-15.051903,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":2929822790.96},{"date":"2022-03-18","current":-17.884701,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3481221099.72},{"date":"2022-03-25","current":-16.435173,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3199073429.96},{"date":"2022-04-01","current":-17.213787,"twenty":-69.499738,"median":-38.495738,"eighty":-30.296587,"marketCap":3350629340.45},{"date":"2022-04-08","current":-16.063966,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":3126818936.54},{"date":"2022-04-14","current":-15.298862,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":2977892925.34},{"date":"2022-04-22","current":-14.712002,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":2863661789.31},{"date":"2022-04-29","current":-13.558507,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":2639136325.07},{"date":"2022-05-06","current":-9.781934,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":1904033919.87},{"date":"2022-05-13","current":-9.355898,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":1821106717.16},{"date":"2022-05-20","current":-8.719868,"twenty":-69.499738,"median":-38.495738,"eighty":-30.192872,"marketCap":1697304784.04},{"date":"2022-05-27","current":-8.314191,"twenty":-69.499738,"median":-38.495738,"eighty":-30.132008,"marketCap":1618340539.42},{"date":"2022-06-03","current":-8.628685,"twenty":-69.499738,"median":-38.495738,"eighty":-30.014085,"marketCap":1679556410.8},{"date":"2022-06-10","current":-9.214019,"twenty":-69.499738,"median":-38.495738,"eighty":-29.921757,"marketCap":1793490418.23},{"date":"2022-06-17","current":-9.914833,"twenty":-69.499738,"median":-38.495738,"eighty":-29.772739,"marketCap":1929902622.2},{"date":"2022-06-24","current":-11.463874,"twenty":-69.529012,"median":-38.500254,"eighty":-29.620948,"marketCap":2231420118.48},{"date":"2022-07-01","current":-11.684606,"twenty":-69.529012,"median":-38.500254,"eighty":-29.322519,"marketCap":2274385364.21},{"date":"2022-07-08","current":-13.343207,"twenty":-69.529012,"median":-38.500254,"eighty":-29.287087,"marketCap":2597228702.6},{"date":"2022-07-15","current":-11.176596,"twenty":-69.529012,"median":-38.500254,"eighty":-29.224911,"marketCap":2175501973.98},{"date":"2022-07-22","current":-11.270185,"twenty":-69.529012,"median":-38.500254,"eighty":-29.070663,"marketCap":2193719071.38},{"date":"2022-07-29","current":-11.175537,"twenty":-69.529012,"median":-38.500254,"eighty":-28.942893,"marketCap":2175295964.08},{"date":"2022-08-05","current":-8.775775,"twenty":-69.251314,"median":-38.382485,"eighty":-28.654578,"marketCap":2238805741.78},{"date":"2022-08-12","current":-9.033436,"twenty":-68.891568,"median":-38.244645,"eighty":-28.437317,"marketCap":2304538127.97},{"date":"2022-08-19","current":-8.567373,"twenty":-68.544113,"median":-38.122097,"eighty":-28.189312,"marketCap":2185639465.6},{"date":"2022-08-26","current":-8.387311,"twenty":-68.170644,"median":-38.040806,"eighty":-28.005292,"marketCap":2139703595.07},{"date":"2022-09-02","current":-8.548157,"twenty":-67.834739,"median":-37.799605,"eighty":-27.755834,"marketCap":2180737445.02},{"date":"2022-09-09","current":-9.050042,"twenty":-67.711165,"median":-37.635536,"eighty":-27.581671,"marketCap":2308774223.62},{"date":"2022-09-16","current":-7.943729,"twenty":-67.568141,"median":-37.567583,"eighty":-27.025151,"marketCap":2026540548.26},{"date":"2022-09-23","current":-5.590294,"twenty":-67.181713,"median":-37.492528,"eighty":-26.772818,"marketCap":1426151024.94},{"date":"2022-09-30","current":-6.0166,"twenty":-66.839726,"median":-37.322153,"eighty":-26.671597,"marketCap":1534906655.67},{"date":"2022-10-07","current":-5.591973,"twenty":-66.311726,"median":-37.125983,"eighty":-26.346066,"marketCap":1426579346.77},{"date":"2022-10-14","current":-5.380359,"twenty":-65.731379,"median":-36.974767,"eighty":-26.200139,"marketCap":1372594209.76},{"date":"2022-10-21","current":-5.717908,"twenty":-65.287627,"median":-36.817162,"eighty":-25.987978,"marketCap":1458706953.83},{"date":"2022-10-28","current":-5.527847,"twenty":-64.824798,"median":-36.677678,"eighty":-25.683533,"marketCap":1410220116.58},{"date":"2022-11-04","current":-5.851883,"twenty":-64.330928,"median":-36.605148,"eighty":-25.425489,"marketCap":1492885555.67},{"date":"2022-11-11","current":-6.401199,"twenty":-64.014025,"median":-36.490673,"eighty":-25.004374,"marketCap":1633022846.35},{"date":"2022-11-18","current":-7.274108,"twenty":-63.706519,"median":-36.322732,"eighty":-24.409241,"marketCap":1855712187.21},{"date":"2022-11-25","current":-7.207228,"twenty":-63.464069,"median":-36.186955,"eighty":-24.11915,"marketCap":1838650480.47},{"date":"2022-12-02","current":-9.190517,"twenty":-63.185779,"median":-36.105478,"eighty":-23.638994,"marketCap":2344610998.55},{"date":"2022-12-09","current":-9.61663,"twenty":-63.052013,"median":-35.941799,"eighty":-23.186635,"marketCap":2453317745.69},{"date":"2022-12-16","current":-9.580976,"twenty":-62.885553,"median":-35.895711,"eighty":-22.098398,"marketCap":2444222152.95},{"date":"2022-12-23","current":-9.787361,"twenty":-62.624453,"median":-35.77363,"eighty":-19.25547,"marketCap":2496873279.39},{"date":"2022-12-30","current":-10.536978,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2688109439.12},{"date":"2023-01-06","current":-11.292055,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2880738826.05},{"date":"2023-01-13","current":-12.006871,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3063096916},{"date":"2023-01-20","current":-11.709152,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2987145347.84},{"date":"2023-01-27","current":-13.678274,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3489492038.73},{"date":"2023-02-03","current":-13.421402,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3423960784.69},{"date":"2023-02-10","current":-11.253893,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2871003089.59},{"date":"2023-02-17","current":-11.126783,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2838575719.48},{"date":"2023-02-24","current":-10.526624,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2685468087.11},{"date":"2023-03-03","current":-8.178091,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2950941580.83},{"date":"2023-03-10","current":-7.048231,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2543248476.73},{"date":"2023-03-17","current":-6.898847,"twenty":-62.129617,"median":-35.521426,"eighty":-17.494664,"marketCap":2489345563.09},{"date":"2023-03-24","current":-6.686154,"twenty":-61.887252,"median":-35.353445,"eighty":-16.993619,"marketCap":2412598207.8},{"date":"2023-03-31","current":-6.37509,"twenty":-61.656831,"median":-35.262393,"eighty":-16.360932,"marketCap":2300355689.58},{"date":"2023-04-06","current":-6.683867,"twenty":-61.173417,"median":-35.179989,"eighty":-15.530351,"marketCap":2411773158.27},{"date":"2023-04-14","current":-8.330975,"twenty":-60.579404,"median":-34.997612,"eighty":-15.233985,"marketCap":3006107420.26},{"date":"2023-04-21","current":-7.844979,"twenty":-58.935582,"median":-34.87491,"eighty":-14.298511,"marketCap":2830742978.45},{"date":"2023-04-28","current":-7.371003,"twenty":-58.19167,"median":-34.698276,"eighty":-13.498182,"marketCap":2659716150.51},{"date":"2023-05-05","current":-7.738249,"twenty":-57.886927,"median":-34.494942,"eighty":-13.330799,"marketCap":2792231115.94},{"date":"2023-05-10","current":-6.689752,"twenty":-57.031699,"median":-34.449204,"eighty":-13.235907,"marketCap":2413896528.97},{"date":"2023-05-19","current":-5.998961,"twenty":-55.865984,"median":-34.307805,"eighty":-12.635355,"marketCap":2164635282.58},{"date":"2023-05-26","current":-6.159383,"twenty":-54.610824,"median":-34.25037,"eighty":-12.304624,"marketCap":2222520838.42},{"date":"2023-06-02","current":-5.896649,"twenty":-53.769073,"median":-34.189583,"eighty":-12.145184,"marketCap":2127717267.98},{"date":"2023-06-09","current":-5.61732,"twenty":-51.214539,"median":-34.098254,"eighty":-11.978924,"marketCap":2026925451.44},{"date":"2023-06-16","current":-6.556151,"twenty":-49.534985,"median":-33.981992,"eighty":-11.716113,"marketCap":2365688683.03},{"date":"2023-06-23","current":-5.188019,"twenty":-48.575977,"median":-33.870975,"eighty":-11.579838,"marketCap":1872018712.18},{"date":"2023-06-30","current":-5.593173,"twenty":-48.355361,"median":-33.644023,"eighty":-11.480192,"marketCap":2018212544.46},{"date":"2023-07-07","current":-5.74663,"twenty":-48.060411,"median":-33.395098,"eighty":-11.347014,"marketCap":2073585481.13},{"date":"2023-07-14","current":-6.162744,"twenty":-47.529274,"median":-33.182708,"eighty":-11.253893,"marketCap":2223733732.38},{"date":"2023-07-21","current":-6.029127,"twenty":-47.271291,"median":-33.060515,"eighty":-11.126783,"marketCap":2175519941.92},{"date":"2023-07-28","current":-6.932729,"twenty":-46.699003,"median":-32.915735,"eighty":-11.040035,"marketCap":2501571410.93},{"date":"2023-08-04","current":-93.761454,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2758743281.53},{"date":"2023-08-11","current":-81.599272,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2400895380.31},{"date":"2023-08-18","current":-77.476828,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2279600704.92},{"date":"2023-08-25","current":-81.532031,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2398916965.04},{"date":"2023-09-01","current":-91.16165,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2682249230.75},{"date":"2023-09-08","current":-82.080837,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2415064449.43},{"date":"2023-09-15","current":-91.04279,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2678752002.43},{"date":"2023-09-22","current":-92.694372,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2727346501.33},{"date":"2023-09-29","current":-98.479468,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2897561388.24},{"date":"2023-10-06","current":-95.557789,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2811596806.75},{"date":"2023-10-13","current":-104.104604,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":3063069736.6},{"date":"2023-10-20","current":-97.193204,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2859715641.7},{"date":"2023-10-27","current":-106.376978,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3129929817.79},{"date":"2023-11-03","current":-113.333081,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3334599265.81},{"date":"2023-11-10","current":-110.227088,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3243211592.97},{"date":"2023-11-17","current":-106.765557,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3141362969.86},{"date":"2023-11-24","current":-109.005881,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3207280038.84},{"date":"2023-12-01","current":-106.403892,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3130721682.86},{"date":"2023-12-08","current":-107.396023,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3159913178.84},{"date":"2023-12-15","current":-114.044196,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3355522389.76},{"date":"2023-12-22","current":-102.844083,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3025981471.63},{"date":"2023-12-29","current":-104.57108,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3076794889.66},{"date":"2024-01-05","current":-97.230433,"twenty":-46.534985,"median":-32.902271,"eighty":-10.987537,"marketCap":2860811039.44},{"date":"2024-01-12","current":-93.788775,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2759547110.77},{"date":"2024-01-19","current":-81.700747,"twenty":-46.617006,"median":-32.897915,"eighty":-10.978873,"marketCap":2403881098.3},{"date":"2024-01-26","current":-75.326321,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2216326338.51},{"date":"2024-02-02","current":-71.131016,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2092887876.59},{"date":"2024-02-09","current":-81.199004,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2389118297.6},{"date":"2024-02-16","current":-84.08213,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2473948515.34},{"date":"2024-02-23","current":-90.549714,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2664244213.15},{"date":"2024-03-01","current":25.78938,"twenty":-46.577409,"median":-32.890218,"eighty":-10.953678,"marketCap":2599053804.56},{"date":"2024-03-08","current":25.462774,"twenty":-45.923863,"median":-32.835083,"eighty":-10.669452,"marketCap":2566138402.88},{"date":"2024-03-15","current":30.565906,"twenty":-45.475099,"median":-32.781518,"eighty":-10.516791,"marketCap":3080431970.72},{"date":"2024-03-22","current":28.107757,"twenty":-45.159274,"median":-32.614784,"eighty":-10.173858,"marketCap":2832699783.36},{"date":"2024-03-28","current":28.634683,"twenty":-44.696755,"median":-32.47029,"eighty":-9.952238,"marketCap":2885803386.55},{"date":"2024-04-05","current":27.994802,"twenty":-44.286361,"median":-32.437839,"eighty":-9.676235,"marketCap":2821316061},{"date":"2024-04-12","current":30.73697,"twenty":-43.790515,"median":-32.383262,"eighty":-9.438819,"marketCap":3097671829.52},{"date":"2024-04-19","current":28.50518,"twenty":-43.289592,"median":-32.314387,"eighty":-9.308641,"marketCap":2872752027.27},{"date":"2024-04-26","current":30.691652,"twenty":-43.110703,"median":-32.225561,"eighty":-9.195832,"marketCap":3093104761.67},{"date":"2024-05-03","current":32.810779,"twenty":-42.925086,"median":-32.090068,"eighty":-9.093044,"marketCap":3306670223.29},{"date":"2024-05-10","current":37.311124,"twenty":-42.754864,"median":-32.013835,"eighty":-9.030734,"marketCap":3760215012.95},{"date":"2024-05-17","current":34.774349,"twenty":-42.519618,"median":-31.926574,"eighty":-8.918389,"marketCap":3504558884.2},{"date":"2024-05-24","current":31.870114,"twenty":-42.406308,"median":-31.731124,"eighty":-8.759961,"marketCap":3211870090.63},{"date":"2024-05-31","current":31.840964,"twenty":-42.321902,"median":-31.616611,"eighty":-8.700526,"marketCap":3208932296.09},{"date":"2024-06-07","current":30.649626,"twenty":-42.069616,"median":-31.52512,"eighty":-8.629123,"marketCap":3088869266.47},{"date":"2024-06-14","current":31.662211,"twenty":-41.839089,"median":-31.349545,"eighty":-8.522865,"marketCap":3190917592.65},{"date":"2024-06-21","current":30.278072,"twenty":-41.728492,"median":-31.238878,"eighty":-8.390524,"marketCap":3051424142.17},{"date":"2024-06-28","current":29.565199,"twenty":-41.372482,"median":-31.203757,"eighty":-8.378139,"marketCap":2979580713.93},{"date":"2024-07-05","current":31.469656,"twenty":-41.171139,"median":-31.162778,"eighty":-8.350361,"marketCap":3171511930.81},{"date":"2024-07-12","current":32.497273,"twenty":-40.923634,"median":-31.106867,"eighty":-8.304192,"marketCap":3275075163.39},{"date":"2024-07-15","current":32.449018,"twenty":-40.883856,"median":-31.083316,"eighty":-8.295844,"marketCap":3270211975.59},{"date":"2024-08-02","current":-73.252444,"twenty":-40.734722,"median":-31.035175,"eighty":-8.234512,"marketCap":3074405105.35},{"date":"2024-08-09","current":-80.817949,"twenty":-40.867508,"median":-31.065396,"eighty":-8.234512,"marketCap":3391929340.66},{"date":"2024-08-16","current":-75.419733,"twenty":-41.029282,"median":-31.08164,"eighty":-8.234512,"marketCap":3165366196.73},{"date":"2024-08-23","current":-70.090937,"twenty":-41.233818,"median":-31.11816,"eighty":-8.234512,"marketCap":2941716616.05},{"date":"2024-08-30","current":-70.200291,"twenty":-41.56077,"median":-31.11816,"eighty":-8.234512,"marketCap":2946306212.08},{"date":"2024-09-06","current":-70.181618,"twenty":-41.811937,"median":-31.11816,"eighty":-8.234512,"marketCap":2945522520.42},{"date":"2024-09-13","current":-69.744859,"twenty":-41.964487,"median":-31.11816,"eighty":-8.234512,"marketCap":2927191709.7},{"date":"2024-09-20","current":-71.615538,"twenty":-42.245335,"median":-31.11816,"eighty":-8.234512,"marketCap":3005704154.39},{"date":"2024-09-27","current":-77.826204,"twenty":-42.356867,"median":-31.178512,"eighty":-8.234512,"marketCap":3266365753.33},{"date":"2024-10-04","current":-82.757332,"twenty":-42.493301,"median":-31.289313,"eighty":-8.234512,"marketCap":3473325219.61},{"date":"2024-10-11","current":-77.57877,"twenty":-42.605,"median":-31.548561,"eighty":-8.234512,"marketCap":3255980971.33},{"date":"2024-10-18","current":-82.642206,"twenty":-42.921343,"median":-31.761378,"eighty":-8.234512,"marketCap":3468493340.62},{"date":"2024-10-25","current":-85.256412,"twenty":-43.016758,"median":-32.001326,"eighty":-8.234512,"marketCap":3578211606.32},{"date":"2024-10-31","current":-74.954799,"twenty":-43.239177,"median":-32.06209,"eighty":-8.234512,"marketCap":3145852920.58},{"date":"2024-11-08","current":-72.692272,"twenty":-43.62805,"median":-32.188654,"eighty":-8.233187,"marketCap":3050894659.02},{"date":"2024-11-15","current":-68.34495,"twenty":-44.002855,"median":-32.188654,"eighty":-8.233187,"marketCap":2868437537.19},{"date":"2024-11-22","current":-71.356956,"twenty":-44.564262,"median":-32.188654,"eighty":-8.233187,"marketCap":2994851469.12},{"date":"2024-11-29","current":-69.444249,"twenty":-44.793919,"median":-32.188654,"eighty":-8.233187,"marketCap":2914575122.66},{"date":"2024-12-06","current":-72.472893,"twenty":-45.245557,"median":-32.188654,"eighty":-8.233187,"marketCap":3041687288.89},{"date":"2024-12-13","current":-63.887587,"twenty":-45.737028,"median":-32.188654,"eighty":-8.233187,"marketCap":2681361994.64},{"date":"2024-12-20","current":-60.618869,"twenty":-46.397964,"median":-32.188654,"eighty":-8.233187,"marketCap":2544173945.26},{"date":"2024-12-27","current":-59.140915,"twenty":-46.839034,"median":-32.188654,"eighty":-8.233187,"marketCap":2482144206.05},{"date":"2025-01-03","current":-61.983512,"twenty":-58.665008,"median":-32.188654,"eighty":-8.233187,"marketCap":2601448012.27},{"date":"2025-01-10","current":-62.344458,"twenty":-60.772335,"median":-32.162743,"eighty":-8.231863,"marketCap":2616596879.5},{"date":"2025-01-17","current":-58.299182,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2446816652.19},{"date":"2025-01-24","current":-55.029289,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2309579252.99},{"date":"2025-01-31","current":-55.715915,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2338396949.9},{"date":"2025-02-07","current":-53.467713,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2244039918.87},{"date":"2025-02-14","current":-55.662649,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2336161367.94},{"date":"2025-02-21","current":-65.870772,"twenty":-61.683916,"median":-32.162743,"eighty":-8.231863,"marketCap":2764596287.73},{"date":"2025-02-28","current":-68.37646,"twenty":-62.164703,"median":-32.162743,"eighty":-8.231863,"marketCap":2869760015.65},{"date":"2025-03-07","current":-68.073966,"twenty":-63.73881,"median":-32.212901,"eighty":-8.230538,"marketCap":2857064342.6},{"date":"2025-03-14","current":-64.060444,"twenty":-64.03835,"median":-32.350855,"eighty":-8.230538,"marketCap":2688616845.96},{"date":"2025-03-21","current":66.690257,"twenty":-64.27493,"median":-32.387163,"eighty":-8.133641,"marketCap":2516156700.16},{"date":"2025-03-28","current":69.598373,"twenty":-64.27493,"median":-32.387163,"eighty":-8.03762,"marketCap":2625877056.17},{"date":"2025-04-04","current":66.45471,"twenty":-64.27493,"median":-32.387163,"eighty":-7.971128,"marketCap":2507269769.7},{"date":"2025-04-11","current":62.287088,"twenty":-64.221309,"median":-32.385213,"eighty":-7.932321,"marketCap":2350029524.92},{"date":"2025-04-17","current":63.677927,"twenty":-64.221309,"median":-32.385213,"eighty":-7.856958,"marketCap":2402504520.39},{"date":"2025-04-25","current":68.867703,"twenty":-64.27493,"median":-32.387163,"eighty":-7.463009,"marketCap":2598309537.11},{"date":"2025-05-02","current":70.00808,"twenty":-64.27493,"median":-32.387163,"eighty":-7.279097,"marketCap":2641334825.25},{"date":"2025-05-09","current":68.704213,"twenty":-64.27493,"median":-32.387163,"eighty":-7.149579,"marketCap":2592141250.63},{"date":"2025-05-16","current":61.687385,"twenty":-64.27493,"median":-32.387163,"eighty":-7.043509,"marketCap":2327403358.61},{"date":"2025-05-23","current":63.281782,"twenty":-64.27493,"median":-32.387163,"eighty":-6.961701,"marketCap":2387558359.74},{"date":"2025-05-30","current":63.269782,"twenty":-64.27493,"median":-32.387163,"eighty":-6.905623,"marketCap":2387105606.22},{"date":"2025-06-06","current":69.305193,"twenty":-64.27493,"median":-32.387163,"eighty":-6.731447,"marketCap":2614815642.59},{"date":"2025-06-13","current":77.57647,"twenty":-64.27493,"median":-32.387163,"eighty":-6.684324,"marketCap":2926882637.05},{"date":"2025-06-20","current":66.613989,"twenty":-64.328552,"median":-32.388787,"eighty":-6.628323,"marketCap":2513279187.31},{"date":"2025-06-27","current":68.13786,"twenty":-64.328552,"median":-32.388787,"eighty":-6.512219,"marketCap":2570773291.5},{"date":"2025-07-03","current":71.210096,"twenty":-64.328552,"median":-32.332621,"eighty":-6.42721,"marketCap":2686685730.87},{"date":"2025-07-11","current":72.572229,"twenty":-64.328552,"median":-32.162743,"eighty":-6.348415,"marketCap":2738077620.44},{"date":"2025-07-18","current":78.450021,"twenty":-64.328552,"median":-32.034774,"eighty":-6.196909,"marketCap":2959840870.68},{"date":"2025-07-25","current":79.176352,"twenty":-64.328552,"median":-31.872185,"eighty":-6.09053,"marketCap":2987244578.9},{"date":"2025-08-01","current":79.150274,"twenty":-64.328552,"median":-31.228469,"eighty":-6.029127,"marketCap":2986260682.88},{"date":"2025-08-08","current":5.542888,"twenty":-64.328552,"median":-31.16064,"eighty":-5.997559,"marketCap":2587874674.36},{"date":"2025-08-15","current":6.05636,"twenty":-64.328552,"median":-31.08164,"eighty":-5.942503,"marketCap":2827605584.52},{"date":"2025-08-22","current":5.906994,"twenty":-64.328552,"median":-30.975476,"eighty":-5.89292,"marketCap":2757868947.74},{"date":"2025-08-29","current":5.520039,"twenty":-64.328552,"median":-30.692254,"eighty":-5.837513,"marketCap":2577207033.23},{"date":"2025-09-05","current":5.773462,"twenty":-64.348416,"median":-30.330097,"eighty":-5.808798,"marketCap":2695525455.08},{"date":"2025-09-12","current":6.495449,"twenty":-64.328552,"median":-30.080885,"eighty":-5.771921,"marketCap":3032608180.86},{"date":"2025-09-19","current":6.361988,"twenty":-64.328552,"median":-29.783366,"eighty":-5.714542,"marketCap":2970297324.15},{"date":"2025-09-26","current":5.650636,"twenty":-64.328552,"median":-29.518985,"eighty":-5.625246,"marketCap":2638180258.96},{"date":"2025-10-03","current":5.974641,"twenty":-64.328552,"median":-29.153616,"eighty":-5.593173,"marketCap":2789452419.21},{"date":"2025-10-10","current":5.77709,"twenty":-64.328552,"median":-28.940995,"eighty":-5.517888,"marketCap":2697219539.83},{"date":"2025-10-17","current":5.438003,"twenty":-64.328552,"median":-27.613233,"eighty":-5.358513,"marketCap":2538905465.8},{"date":"2025-10-24","current":5.566179,"twenty":-64.328552,"median":-26.616683,"eighty":-5.24792,"marketCap":2598748900.26},{"date":"2025-10-31","current":5.323193,"twenty":-64.328552,"median":-26.259383,"eighty":5.316035,"marketCap":2485303049.86},{"date":"2025-11-07","current":5.692673,"twenty":-64.328552,"median":-25.831006,"eighty":5.422523,"marketCap":2657806660.11},{"date":"2025-11-14","current":5.538607,"twenty":-64.328552,"median":-25.574426,"eighty":5.520039,"marketCap":2585875851.6},{"date":"2025-11-21","current":5.228746,"twenty":-64.328552,"median":-25.210285,"eighty":5.538607,"marketCap":2441207293.13},{"date":"2025-11-28","current":5.415727,"twenty":-64.328552,"median":-23.125526,"eighty":5.538607,"marketCap":2528505283.04},{"date":"2025-12-05","current":5.234536,"twenty":-64.328552,"median":-17.960601,"eighty":5.538607,"marketCap":2443910845.71},{"date":"2025-12-12","current":5.038573,"twenty":-64.328552,"median":-17.484256,"eighty":5.538607,"marketCap":2352418929.73},{"date":"2025-12-19","current":4.906191,"twenty":-64.328552,"median":-16.980776,"eighty":5.538607,"marketCap":2290612111.23},{"date":"2025-12-26","current":4.891268,"twenty":-64.328552,"median":-16.438933,"eighty":5.538607,"marketCap":2283644877.95},{"date":"2026-01-02","current":5.059143,"twenty":-64.328552,"median":-15.7025,"eighty":5.538607,"marketCap":2362022580.17},{"date":"2026-01-09","current":5.365899,"twenty":-64.328552,"median":-15.255817,"eighty":5.538607,"marketCap":2505241950.3},{"date":"2026-01-16","current":5.891548,"twenty":-64.328552,"median":-14.764247,"eighty":5.547002,"marketCap":2750658052.81},{"date":"2026-01-23","current":5.589246,"twenty":-64.328552,"median":-13.552429,"eighty":5.564767,"marketCap":2609518309.27},{"date":"2026-01-30","current":5.579629,"twenty":-64.328552,"median":-13.378369,"eighty":5.577919,"marketCap":2605028588.75},{"date":"2026-02-06","current":5.333987,"twenty":-64.328552,"median":-13.08706,"eighty":5.577919,"marketCap":2490342690.22},{"date":"2026-02-13","current":5.391763,"twenty":-64.328552,"median":-12.446216,"eighty":5.577919,"marketCap":2517316830.13},{"date":"2026-02-20","current":5.446666,"twenty":-64.328552,"median":-12.223865,"eighty":5.577919,"marketCap":2542950715.44},{"date":"2026-02-27","current":5.347907,"twenty":-64.328552,"median":-12.057036,"eighty":5.577919,"marketCap":2496841437.87},{"date":"2026-03-06","current":5.35443,"twenty":-64.328552,"median":-11.756142,"eighty":5.577919,"marketCap":2446487432.17},{"date":"2026-03-13","current":5.276227,"twenty":-64.328552,"median":-11.587891,"eighty":5.577919,"marketCap":2410755580.04},{"date":"2026-03-20","current":5.082388,"twenty":-64.328552,"median":-11.511707,"eighty":5.577919,"marketCap":2322188528.68},{"date":"2026-03-27","current":4.945113,"twenty":-64.328552,"median":-11.319534,"eighty":5.577919,"marketCap":2259466792.96}],"updateTime":1774752107335},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HCM\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2601002283","title":"Malaysian Shares Rebound Mirroring Regional Gains; Vetece's Shares Rise 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601002283","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601002283?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:41","pubTimestamp":1767606115,"startTime":"0","endTime":"0","summary":"Malaysian stocks rose slightly on Monday, snapping a two-day losing streak, and in line with regional gains.The FTSE Bursa Malaysia KLCI gained 10.56 points to end 0.6% higher at 1,680.32. The day range was between 1,669.08 and 1,681.94.In corporate news, shares of Vetece  gained over 4% on Monday's close after its unit Vision Technology Consulting signed a contract with a leading Malaysian utility company to provide an international Human Capital Management  Cloud software subscription valued at about 12.6 million ringgit.Whereas, shares of Glomac  slid over 1% on close after its unit Glomac Al Batha agreed to sell two leasehold plots in Puchong, Malaysia, for 97.3 million to Sunway Kiara.Meanwhile, Guan Huat Seng  is seeking to raise about 30 million ringgit from its initial public offering on the ACE Market of Bursa Malaysia. The IPO entails a public issue of 120 million shares at a tentative price of 0.25 ringgit each, as well as an offer for sale of 21 million shares.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4531","HCM","BK4588","BK4007","BK4585"],"gpt_icon":0},{"id":"2601526002","title":"Hutchmed Starts Phase III Trial of Pancreatic Cancer Treatment Combination","url":"https://stock-news.laohu8.com/highlight/detail?id=2601526002","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601526002?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:31","pubTimestamp":1767605469,"startTime":"0","endTime":"0","summary":"Hutchmed (HCM) said Sunday it started a phase III of its trial to evaluate the efficacy of the combination of surufatinib, camrelizumab, nab-paclitaxel and gemcitabine to treat adults with metastatic ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["III","BK4007","BK4531","HCM","BK4134","BK4588","BK4585"],"gpt_icon":0},{"id":"2601008906","title":"Vetece Unit Wins About MYR13 Million HCM Cloud Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2601008906","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601008906?lang=en_us&edition=fundamental","pubTime":"2026-01-05 14:37","pubTimestamp":1767595052,"startTime":"0","endTime":"0","summary":"Vetece  unit Vision Technology Consulting signed a contract with a leading Malaysian utility company to provide an international Human Capital Management  Cloud software subscription valued at about 12.6 million ringgit, according to a Friday Malaysian bourse filing.Shares of the enterprise IT services provider slid 2% in Monday's midday trade.The project is expected to be delivered over the financial years ending Aug. 31, 2026 to Aug. 31, 2029.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4531","HCM","BK4588","BK4585","BK4007"],"gpt_icon":0},{"id":"1168150943","title":"HUTCHMED (00013) Initiates Phase III Stage of Ongoing Study of Surufatinib Combined with Camrelizumab for Treatment-Naïve Pancreatic Ductal Adenocarcinoma","url":"https://stock-news.laohu8.com/highlight/detail?id=1168150943","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168150943?lang=en_us&edition=fundamental","pubTime":"2026-01-05 08:12","pubTimestamp":1767571948,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced today the initiation of the Phase III portion of its China-based Phase II/III study evaluating surufatinib in combination with camrelizumab, nab-paclitaxel, and gemcitabine...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK1587","HCM","BK4134","III","BK4585","BK1191","BK1588","BK4531","00013","BK4007"],"gpt_icon":0},{"id":"2595079982","title":"Hutchmed Says New Application for Gastric Cancer Treatment Gets Priority Review in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2595079982","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595079982?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:49","pubTimestamp":1767091750,"startTime":"0","endTime":"0","summary":"Hutchmed  said Tuesday the China National Medical Products Administration has granted priority review to the company's new drug application for savolitinib to treat locally advanced or metastatic gastric cancer or gastroesophageal junction adenocarcinoma patients.The specific indication is for patients with MET amplification who have failed at least two previous systemic treatments, according to the company.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","HCM","BK4585","BK4531","BK4007"],"gpt_icon":0},{"id":"1139978406","title":"HUTCHMED (00013) Announces NDA Acceptance and Priority Review Status in China for Savolitinib in MET-Amplified Gastric Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=1139978406","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1139978406?lang=en_us&edition=fundamental","pubTime":"2025-12-30 18:10","pubTimestamp":1767089426,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced that the New Drug Application (NDA) for savolitinib has been accepted by the China National Medical Products Administration (NMPA) and granted priority review. The...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1989772840.SGD","LU1496350502.SGD","MET","BK4007","LU1291159041.SGD","LU1989772923.USD","LU1989771016.USD","BK4585","BK1587","BK1588","BK1191","BK4588","BK4531","HCM","00013","BK4162"],"gpt_icon":0},{"id":"2595786132","title":"Hutchmed Says Chinese Regulator Granted Priority Review Status to New Drug Application for Fanregratinib","url":"https://stock-news.laohu8.com/highlight/detail?id=2595786132","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595786132?lang=en_us&edition=fundamental","pubTime":"2025-12-29 17:45","pubTimestamp":1767001518,"startTime":"0","endTime":"0","summary":"Hutchmed  said Monday that the China National Medical Products Administration accepted the new drug application for fanregratinib as a potential treatment for adult patients with advanced, metastatic or unresectable intrahepatic cholangiocarcinoma and gave the application priority review status.The company said the application is backed by data from a phase 2 study in China, which met its primary endpoint of objective response rate.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["HCM","BK4588","BK4007","BK4585","BK4531"],"gpt_icon":0},{"id":"1190145372","title":"HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review","url":"https://stock-news.laohu8.com/highlight/detail?id=1190145372","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190145372?lang=en_us&edition=fundamental","pubTime":"2025-12-29 16:41","pubTimestamp":1766997665,"startTime":"0","endTime":"0","summary":"tags.  HUTCHMED (00013): NDA for Fanregratinib (HMPL-453) as Second-Line Treatment for Intrahepatic Cholangiocarcinoma Accepted in China with Priority Review HUTCHMED (00013) announced that the New...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCM","BK1588","BK4007","00013","BK4531","BK1587","BK1191","BK4588","BK4585"],"gpt_icon":0},{"id":"2592050197","title":"Cytokinetics Announces FDA Approval of MYQORZO™ (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy to Improve Functional Capacity and Symptoms","url":"https://stock-news.laohu8.com/highlight/detail?id=2592050197","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592050197?lang=en_us&edition=fundamental","pubTime":"2025-12-20 05:00","pubTimestamp":1766178000,"startTime":"0","endTime":"0","summary":"MYQORZO, a Cardiac Myosin Inhibitor, Directly Addresses Underlying Hypercontractility Associated with Obstructive HCM FDA Approval Based on Results of SEQUOIA-HCM  MYQORZO is Company’s First FDA-Appro","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/19/3208724/35409/en/Cytokinetics-Announces-FDA-Approval-of-MYQORZO-aficamten-for-the-Treatment-of-Adults-with-Symptomatic-Obstructive-Hypertrophic-Cardiomyopathy-to-Improve-Functional-Capacity-and-Sym.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","HCMA","BK4007","BK4139","BK4585","BK4588","BK4531","HCM","CYTK"],"gpt_icon":0},{"id":"2592997151","title":"Cytokinetics Announces NMPA Approval of MYQORZO® (aficamten) in China  for Patients with Obstructive Hypertrophic Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2592997151","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592997151?lang=en_us&edition=fundamental","pubTime":"2025-12-17 20:30","pubTimestamp":1765974600,"startTime":"0","endTime":"0","summary":"Approval Triggers Milestone Payment of $7.5 Million from Sanofi;Cytokinetics Eligible to Receive Additional Milestone Payments and Royalties on Net Sales in Greater China SOUTH SAN FRANCISCO, Calif., ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/17/3206907/35409/en/Cytokinetics-Announces-NMPA-Approval-of-MYQORZO-aficamten-in-China-for-Patients-with-Obstructive-Hypertrophic-Cardiomyopathy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4531","HCM","CYTK","BK4156","BK4087","BK4505","BK4139","BK4585","BK4007","CHMP"],"gpt_icon":0},{"id":"2592912809","title":"Hutchmed Begins Phase 1 Study of HMPL-A251 Monotherapy to Treat Patients With Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2592912809","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592912809?lang=en_us&edition=fundamental","pubTime":"2025-12-17 19:20","pubTimestamp":1765970429,"startTime":"0","endTime":"0","summary":"Hutchmed  said Wednesday it has initiated a global phase 1 clinical development program for its HMPL-A251 monotherapy candidate derived from the company's ATTC platform, in patients with solid tumors.The first patient was dosed on Tuesday in China, the company said.Hutchmed said the primary outcome measures of the study are to evaluate the safety and tolerability of HMPL-A251 and to determine the maximum tolerated dose and recommended dose for expansion in the first phase of the trial. In the following phases, further safety evaluation and preliminary efficacy at recommended doses will be studied.Secondary outcome measures of the study include preliminary antitumor activity, pharmacokinetic profile, and the immunogenicity of HMPL-A251, the company said.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4588","HCM","BK4585","BK4531","BK4007"],"gpt_icon":0},{"id":"1168135280","title":"HUTCHMED (00013) Initiates Global Clinical Development of ATTC Candidate HMPL-A251 for Solid Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=1168135280","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168135280?lang=en_us&edition=fundamental","pubTime":"2025-12-17 08:18","pubTimestamp":1765930716,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced the initiation of a global Phase I clinical development program for HMPL-A251. HMPL-A251 is a first-in-class PI3K/PIKK-HER2 antibody-targeted conjugate (ATTC), composed of...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK1191","HCM","BK1588","00013","BK1587","BK4007","BK4588","BK4585"],"gpt_icon":0},{"id":"2592930382","title":"Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2592930382","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592930382?lang=en_us&edition=fundamental","pubTime":"2025-12-17 05:00","pubTimestamp":1765918800,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  16, 2025  (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that on December 15, 2025 it granted stock options to purchase an aggregate o","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/16/3206592/35409/en/Cytokinetics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-C-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106831901.USD","LU0130517989.USD","BK4504","LU0170899867.USD","LU0052756011.USD","LU0128525689.USD","LU1366192091.USD","LU2456880835.USD","CYTK","LU1244550494.USD","LU0477156953.USD","LU1201861249.SGD","BK4139","BK4566","BK4007","LU0310800965.SGD","LU0162691827.USD","HCM","LU0648001328.SGD","BK4505","LU2125154778.USD","BK4534","BK4531","LU2462157665.USD","LU0980610538.SGD","LU1244550221.USD","LU1162221912.USD","BK4588","BK4207","LU0098860793.USD","LU2417539215.USD","BK4559","LU0130102774.USD","LU2125154935.USD","LU1244550577.SGD","IE00BSNM7G36.USD","LU0320765646.SGD","LU0072461881.USD","LU1791807156.HKD","BK4585","LU2360032135.SGD","LU1668664300.SGD","LU2236285917.USD","LU1267930227.SGD"],"gpt_icon":0},{"id":"2591684828","title":"Press Release: UKG Agrees to Acquire Inova Payroll","url":"https://stock-news.laohu8.com/highlight/detail?id=2591684828","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591684828?lang=en_us&edition=fundamental","pubTime":"2025-12-13 05:51","pubTimestamp":1765576260,"startTime":"0","endTime":"0","summary":"Acquisition Strengthens Ability to Directly Support Small and Mid-Sized Businesses with Expanded Service Offerings. UKG Inc., a leading global AI platform unifying HR, pay, and workforce management, has entered into a definitive agreement to acquire Inova Payroll, a U.S.-based human capital management  and payroll services provider for small and mid-sized businesses . The acquisition, which is subject to customary closing conditions, will enable UKG to directly provide the SMB market segment with innovative outsourced HR support and full benefits brokerage services.Based in Nashville, Tennessee, Inova serves more than 4,000 businesses. As the largest reseller of the UKG Ready suite nationwide, Inova enhances HR operations through outsourced expertise and robust benefits support, helping employers more easily manage everyday HR tasks and compliance to better serve employees. Targeted third-party technology integrations help streamline essential processes and reduce manual effort.Inova h","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCM","R","BK4022","BK4007","BK4232","BK4531","BK4588","BK4585"],"gpt_icon":0},{"id":"2590454151","title":"Tenaya Therapeutics Announces Proposed Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2590454151","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590454151?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:02","pubTimestamp":1765486920,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Dec.  11, 2025  (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (Nasdaq: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potent","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204290/0/en/Tenaya-Therapeutics-Announces-Proposed-Public-Offering.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","HCM","TNYA","BK4585","BK4539","BK4531","BK4007","BK4139"],"gpt_icon":0},{"id":"2590415455","title":"Tenaya Therapeutics Reports Positive Interim Data from Cohort 1 of RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Gene Therapy for Adults with PKP2-associated ARVC","url":"https://stock-news.laohu8.com/highlight/detail?id=2590415455","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590415455?lang=en_us&edition=fundamental","pubTime":"2025-12-12 05:01","pubTimestamp":1765486860,"startTime":"0","endTime":"0","summary":"TN-401 was Well Tolerated at 3E13 vg/kg doseRobust Transduction and Demonstrated Increases in PKP2 Protein Levels in First Two Patients at Week 8Clinically Meaningful Reductions in Arrhythmia Burden O","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/11/3204284/0/en/Tenaya-Therapeutics-Reports-Positive-Interim-Data-from-Cohort-1-of-RIDGE-1-Phase-1b-2-Clinical-Trial-of-TN-401-Gene-Therapy-for-Adults-with-PKP2-associated-ARVC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4516","BK4531","BK4139","LU1861219969.SGD","LU1939255532.USD","LU0689626769.HKD","HCM","BK4588","BK4585","LU1861214812.USD","LU0187121727.USD","BK4539","LU0124676726.USD","LU2308191902.HKD","BK4129","LU2360107325.USD","LU2244417387.USD","TNYA","ACM","LU2298064838.USD","BK4007","LU2238339852.HKD"],"gpt_icon":0},{"id":"2590654265","title":"ADP Unveils Lyric HCM in Australia and New Zealand","url":"https://stock-news.laohu8.com/highlight/detail?id=2590654265","media":"prnewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590654265?lang=en_us&edition=fundamental","pubTime":"2025-12-11 11:30","pubTimestamp":1765423800,"startTime":"0","endTime":"0","summary":"A flexible, intelligent and more human way to manage people. MELBOURNE, Australia, Dec. 11, 2025 /PRNewswire/ -- ADP, a global leader in HR and payroll solutions, has rolled out ADP Lyric HCM across Australia and New Zealand  – an AI-powered, award-winning platform that brings together payroll, HR, and people experience in one unified ecosystem.First launched in the United States in 2024, Lyric has quickly gained traction for its human-centered design and flexibility. Building on that success, the platform has now been deployed and testedfor the ANZ market to address regional compliance requirements and workplace needs.A recent survey by the Australian Payroll Association revealed that one in three Australian companies reported not completing a payroll compliance audit in the past three years, and many cited keeping up with legislation as one of their biggest challenge1. Lyric directly addresses these issues with always-on payroll calculations, automated downstream payments, and audit-","market":"other","thumbnail":"https://mma.prnewswire.com/media/832721/ADP_Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/832721/ADP_Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/adp-unveils-lyric-hcm-in-australia-and-new-zealand-302638189.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ANZ.AU","LU1934455194.USD","LU1934455863.HKD","BK4531","LU1228905540.USD","LU0965508806.USD","LU1228905037.USD","LU0965509101.SGD","HCM","IE00B5TLWC47.USD","LU0950375773.USD","NZ20C.NZ","XKO.AU","LU0289941410.SGD","LU0545562505.USD","NZ50G.NZ","LU1934455277.USD","BK4528","BK4007","BK7135","LU0861579265.USD","LU2404859741.USD","IE00BYQQ9H92.USD","BK7511","T10G.NZ","LU1032955483.USD","LU0965509283.SGD","LU0823417737.USD","GB00B4QBRK32.GBP","XAO.AU","LU2506952170.USD","LU0690374961.EUR","ADP","LU2506951875.HKD","XJO.AU","BK4588","LU2404859667.USD","LU1236620834.HKD","BK4130","LU0345774391.USD","BK4106","LU0345774631.USD","LU2506952097.USD","LU1236620750.USD","GB00B4LPDJ14.GBP","LU1221951129.SGD","LU1037948541.HKD","LU1037948897.HKD","LU0690374615.EUR","LU1221951046.USD"],"gpt_icon":0},{"id":"1147683724","title":"HUTCHMED (00013): TAZVERIK® Included in the First National Commercial Health Insurance Innovative Drug List","url":"https://stock-news.laohu8.com/highlight/detail?id=1147683724","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1147683724?lang=en_us&edition=fundamental","pubTime":"2025-12-08 08:18","pubTimestamp":1765153099,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced that following the renewal of the national medical insurance agreement with China's National Healthcare Security Administration (NHSA), ELUNATE®, ORPATHYS®, and SULANDA®...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4531","BK4007","BK1588","BK1587","BK1191","00013","HCM","BK4585","BK4588"],"gpt_icon":0},{"id":"2589124890","title":"Clinical Data on Effect of Sotagliflozin on Adipose Distribution in Non-Diabetic Patients will be Presented at the 2025 Cardio Vascular Clinical Trialists Forum","url":"https://stock-news.laohu8.com/highlight/detail?id=2589124890","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589124890?lang=en_us&edition=fundamental","pubTime":"2025-12-05 21:30","pubTimestamp":1764941400,"startTime":"0","endTime":"0","summary":"THE WOODLANDS, Texas, Dec.  05, 2025  (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced clinical data on adipose tissue distribution in non-diabetic patients treated with sota","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/12/05/3200707/0/en/Clinical-Data-on-Effect-of-Sotagliflozin-on-Adipose-Distribution-in-Non-Diabetic-Patients-will-be-Presented-at-the-2025-Cardio-Vascular-Clinical-Trialists-Forum.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4585","BK4179","HCM","BK4531","FET","BK4007"],"gpt_icon":0},{"id":"2588710656","title":"AI-Powered Event Notifications Might Change the Case for Investing in Paychex (PAYX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588710656","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588710656?lang=en_us&edition=fundamental","pubTime":"2025-12-01 08:23","pubTimestamp":1764548587,"startTime":"0","endTime":"0","summary":"In November 2025, Paychex introduced participant Event Notifications, an AI-powered wealth management solution for financial advisors, alongside significant enhancements to its 401(k) retirement plan platform, including new payroll integrations, updated user interfaces, and expanded cybersecurity measures.\nThis launch positions Paychex as a more comprehensive provider in the retirement and wealth management space, offering advisors real-time opportunities to engage participants at pivotal...","market":"hk","thumbnail":"https://images.simplywall.st/asset/company-cover/295368-main-header/1756255308320","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/295368-main-header/1756255308320"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/commercial-services/nasdaq-payx/paychex/news/ai-powered-event-notifications-might-change-the-case-for-inv","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/commercial-services/nasdaq-payx/paychex/news/ai-powered-event-notifications-might-change-the-case-for-inv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SG9999001440.SGD","PAYX","BK4007","IE00BVYPNV92.GBP","BK4588","LU0738911758.USD","BK4106","IE00B3PB1722.GBP","IE00BVYPNW00.USD","HCM","BK4531","BK4130","BK4585","IE00B3T34201.USD","LU0661504455.SGD","IE00B42XCP33.USD","LU0949170772.SGD","IE00BGHQF631.EUR","IE00BDGV0183.EUR"],"gpt_icon":0}],"pageSize":20,"totalPage":6,"pageCount":4,"totalSize":117,"code":"91000000","status":"200"}]}}